IVF device market seen reaching $31.23 billion by 2030

The global in vitro fertilization device market is projected to grow from $22.32 billion in 2026 to $31.23 billion by 2030, driven by rising infertility rates, delayed parenthood and broader fertility clinic access. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - IVF devices support fertility treatment workflows that depend on precise lab conditions, including temperature, humidity, gas levels and sterile handling. - Rising infertility and later family formation are keeping demand for assisted reproductive technologies elevated worldwide. - The market outlook points to continued growth in fertility infrastructure, cryopreservation and more accessible IVF care.

What happened: - The Business Research Company released its Global Market Report 2026 on the in vitro fertilization device market. - The market is estimated at $22.32 billion in 2026, up from $20.44 billion in 2025. - The report projects the market will reach $31.23 billion by 2030. - The forecast implies an 8.8% CAGR from 2026 to 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - IVF devices are specialized medical tools used to facilitate fertilization outside the human body under controlled lab conditions. - The devices support embryo culture, sperm preparation, egg retrieval assistance and microscopic examination. - Market growth has been supported by the rising prevalence of infertility, expansion of fertility clinics, improved IVF success rates and basic embryo culture and laboratory systems. - Greater awareness of assisted reproductive technologies has also helped demand. - Future growth is expected to come from delayed parenthood, higher government reimbursement, broader insurance coverage, fertility tourism, adoption in emerging economies and wider use of cryopreservation for fertility preservation. - Key trends include single embryo transfer protocols, egg freezing, better affordability, standardized lab quality control and demand for portable, modular IVF lab setups in emerging markets. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - A free sample report is available here. - The full report is available here.

Between the lines: - The market forecast reflects a broader shift toward fertility treatment as a mainstream healthcare category rather than a niche service. - The regional split suggests mature demand in North America and faster capacity buildout in Asia-Pacific. - The emphasis on modular lab systems and cryopreservation points to a market that is evolving toward flexibility, scale and fertility preservation. - England and Wales recorded a total fertility rate of 1.41 children per woman in 2024, down from 1.42 in 2023, underscoring the persistence of low fertility trends.

What's next: - The report expects delayed parenthood, reimbursement support and emerging-market adoption to keep lifting demand through 2030. - IVF providers and suppliers are likely to focus more on portable lab formats, quality-control standardization and preservation technologies. - Market attention will likely remain centered on clinic expansion, pricing access and regional growth in Asia-Pacific.